Parkinson's Disease (PD) Drugs Market Report

China Parkinson's Disease (PD) Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：169
  • REPORT CODE：GMM1844442
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease (PD) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Biogen

    • H Lundbeck

    • Addex Therapeutics

    • GlaxoSmithKline

    • Otsuka Pharmaceutical

    • Impax Laboratories

    • Pfizer

    • Teva Pharmaceutical Industries

    • Novartis

    • Kyowa Hakko Kirin

    • Eisai

    • F Hoffmann-La Roche

    • Boehringer Ingelheim

    By Type:

    • Acetylcholinesterase Inhibitors

    • Glutamate Inhibitors

    • Monoamine Oxidase Inhibitors

    • Dopamine Agonist

    By Application:

    • Family

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Parkinson's Disease (PD) Drugs Market Overview 2018-2029

    • 1.1 China Parkinson's Disease (PD) Drugs Industry Development Overview

    • 1.2 China Parkinson's Disease (PD) Drugs Industry Development History

    • 1.3 China Parkinson's Disease (PD) Drugs Industry Market Size (2018-2029)

    • 1.4 China Parkinson's Disease (PD) Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Acetylcholinesterase Inhibitors (2018-2029)

      • 1.4.2 China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Glutamate Inhibitors (2018-2029)

      • 1.4.3 China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Monoamine Oxidase Inhibitors (2018-2029)

      • 1.4.4 China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Dopamine Agonist (2018-2029)

    • 1.5 China Parkinson's Disease (PD) Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate of Family (2018-2029)

      • 1.5.2 China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Parkinson's Disease (PD) Drugs Market Analysis by Region

      • 1.6.1 North China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Parkinson's Disease (PD) Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Parkinson's Disease (PD) Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Parkinson's Disease (PD) Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Parkinson's Disease (PD) Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Parkinson's Disease (PD) Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Parkinson's Disease (PD) Drugs Industry Development

    Chapter 3 Parkinson's Disease (PD) DrugsIndustry Chain Analysis

    • 3.1 Parkinson's Disease (PD) Drugs Industry Chain

    • 3.2 Parkinson's Disease (PD) Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Parkinson's Disease (PD) Drugs Market

    • 3.3 Parkinson's Disease (PD) Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Parkinson's Disease (PD) Drugs Market

    Chapter 4 China Parkinson's Disease (PD) Drugs Market, by Type

    • 4.1 China Parkinson's Disease (PD) Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Parkinson's Disease (PD) Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Acetylcholinesterase Inhibitors

      • 4.5.2 China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Glutamate Inhibitors

      • 4.5.3 China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Monoamine Oxidase Inhibitors

      • 4.5.4 China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Dopamine Agonist

    Chapter 5 China Parkinson's Disease (PD) Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Parkinson's Disease (PD) Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Parkinson's Disease (PD) Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Family

      • 5.5.2 China Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Hospital

    Chapter 6 China Parkinson's Disease (PD) Drugs Market, by Region

    • 6.1 China Parkinson's Disease (PD) Drugs Production Volume and Production Value, by Region

    • 6.2 China Parkinson's Disease (PD) Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Parkinson's Disease (PD) Drugs Market Analysis

    • 7.1 North China Parkinson's Disease (PD) Drugs Market, by Type

    • 7.2 North China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 8 Central China Parkinson's Disease (PD) Drugs Market Analysis

    • 8.1 Central China Parkinson's Disease (PD) Drugs Market, by Type

    • 8.2 Central China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 9 South China Parkinson's Disease (PD) Drugs Market Analysis

    • 9.1 South China Parkinson's Disease (PD) Drugs Market, by Type

    • 9.2 South China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 10 East China Parkinson's Disease (PD) Drugs Market Analysis

    • 10.1 East China Parkinson's Disease (PD) Drugs Market, by Type

    • 10.2 East China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 11 Northeast China Parkinson's Disease (PD) Drugs Market Analysis

    • 11.1 Northeast China Parkinson's Disease (PD) Drugs Market, by Type

    • 11.2 Northeast China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 12 Southwest China Parkinson's Disease (PD) Drugs Market Analysis

    • 12.1 Southwest China Parkinson's Disease (PD) Drugs Market, by Type

    • 12.2 Southwest China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 13 Northwest China Parkinson's Disease (PD) Drugs Market Analysis

    • 13.1 Northwest China Parkinson's Disease (PD) Drugs Market, by Type

    • 13.2 Northwest China Parkinson's Disease (PD) Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Biogen

        • 14.1.1 Biogen Company Profile

        • 14.1.2 Biogen Parkinson's Disease (PD) Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 H Lundbeck

        • 14.2.1 H Lundbeck Company Profile

        • 14.2.2 H Lundbeck Parkinson's Disease (PD) Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Addex Therapeutics

        • 14.3.1 Addex Therapeutics Company Profile

        • 14.3.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline

        • 14.4.1 GlaxoSmithKline Company Profile

        • 14.4.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Otsuka Pharmaceutical

        • 14.5.1 Otsuka Pharmaceutical Company Profile

        • 14.5.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Impax Laboratories

        • 14.6.1 Impax Laboratories Company Profile

        • 14.6.2 Impax Laboratories Parkinson's Disease (PD) Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Parkinson's Disease (PD) Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical Industries

        • 14.8.1 Teva Pharmaceutical Industries Company Profile

        • 14.8.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis

        • 14.9.1 Novartis Company Profile

        • 14.9.2 Novartis Parkinson's Disease (PD) Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Kyowa Hakko Kirin

        • 14.10.1 Kyowa Hakko Kirin Company Profile

        • 14.10.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Eisai

        • 14.11.1 Eisai Company Profile

        • 14.11.2 Eisai Parkinson's Disease (PD) Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 F Hoffmann-La Roche

        • 14.12.1 F Hoffmann-La Roche Company Profile

        • 14.12.2 F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Boehringer Ingelheim

        • 14.13.1 Boehringer Ingelheim Company Profile

        • 14.13.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Parkinson's Disease (PD) Drugs Industry Research Conclusions

    • 15.2 Parkinson's Disease (PD) Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Parkinson's Disease (PD) Drugs Industry Market Size (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Acetylcholinesterase Inhibitors (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Glutamate Inhibitors (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Monoamine Oxidase Inhibitors (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume, Production Value and Growth Rate of Dopamine Agonist (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate of Family (2018-2029)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Parkinson's Disease (PD) Drugs Market Size and Growth Rate from 2018-2029

    • Figure Parkinson's Disease (PD) Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Parkinson's Disease (PD) Drugs Market Share by Type in 2018

    • Figure China Parkinson's Disease (PD) Drugs Market Share by Type in 2023

    • Figure China Parkinson's Disease (PD) Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Acetylcholinesterase Inhibitors (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Glutamate Inhibitors (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Monoamine Oxidase Inhibitors (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume and Growth Rate of Dopamine Agonist (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Market Share by Application in 2018

    • Figure China Parkinson's Disease (PD) Drugs Market Share by Application in 2023

    • Figure China Parkinson's Disease (PD) Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Family (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Production Volume by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Production Volume Share by Region (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Volume Share by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Production Value by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Production Value Share by Region (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Production Value Share by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume Share by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Sales Value by Region (2018-2023)

    • Table China Parkinson's Disease (PD) Drugs Sales Value Share by Region (2018-2023)

    • Figure China Parkinson's Disease (PD) Drugs Sales Value Share by Region (2018-2023)

    • Table North China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table North China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table North China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table North China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table Central China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table Central China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table South China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table South China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table South China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table East China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table East China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table East China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Parkinson's Disease (PD) Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Parkinson's Disease (PD) Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Parkinson's Disease (PD) Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Parkinson's Disease (PD) Drugs Sales Volume Share by Application (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table H Lundbeck Company Profile

    • Table H Lundbeck Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Addex Therapeutics Company Profile

    • Table Addex Therapeutics Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Otsuka Pharmaceutical Company Profile

    • Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Impax Laboratories Company Profile

    • Table Impax Laboratories Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Company Profile

    • Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Company Profile

    • Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Eisai Company Profile

    • Table Eisai Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Company Profile

    • Table F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US